Orally administered melatonin reduces oxidative stress and proinflammatory cytokines induced by amyloid-β peptide in rat brain:: a comparative, in vivo study versus vitamin C and E

被引:111
作者
Rosales-Corral, S
Tan, DX
Reiter, RJ
Valdivia-Velázquez, M
Martínez-Barboza, G
Acosta-Martínez, JP
Ortiz, GG
机构
[1] Occidente Inst Mexicano Seguro Social, Ctr Invest Biomed, Guadalajara, Jalisco, Mexico
[2] Univ Texas, Hlth Sci Ctr, Dept Cellular & Struct Biol, San Antonio, TX 78284 USA
关键词
antioxidants; melatonin; amyloid-beta; neuroinflammatory cytokines; oxidative stress;
D O I
10.1034/j.1600-079X.2003.00057.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
To determine the efficacy of antioxidants in reducing amyloid-beta -induced oxidative stress, and the neuroinflammatory response in the central nervous system (CNS) in vivo, three injections of fibrillar amyloid-beta (fAbeta ) or artificial cerebrospinal fluid (aCSF) into the CA1 region of the hippocampus of the rat were made. Concomitantly, one of the three free radical scavengers, i.e. melatonin, vitamin C, or vitamin E was also administered. Besides being a free radical scavenger, melatonin also has immunomodulatory functions. Antioxidant treatment reduced significantly oxidative stress and pro-inflammatory cytokines. There were no marked differences between melatonin, vitamin C, and vitamin E regarding their capacity to reduce nitrites and lipoperoxides. However, melatonin exhibited a superior capacity to reduce the pro-inflammatory response induced by fAbeta .
引用
收藏
页码:80 / 84
页数:5
相关论文
共 31 条
  • [1] Inflammation and Alzheimer's disease
    Akiyama, H
    Barger, S
    Barnum, S
    Bradt, B
    Bauer, J
    Cole, GM
    Cooper, NR
    Eikelenboom, P
    Emmerling, M
    Fiebich, BL
    Finch, CE
    Frautschy, S
    Griffin, WST
    Hampel, H
    Hull, M
    Landreth, G
    Lue, LF
    Mrak, R
    Mackenzie, IR
    McGeer, PL
    O'Banion, MK
    Pachter, J
    Pasinetti, G
    Plata-Salaman, C
    Rogers, J
    Rydel, R
    Shen, Y
    Streit, W
    Strohmeyer, R
    Tooyoma, I
    Van Muiswinkel, FL
    Veerhuis, R
    Walker, D
    Webster, S
    Wegrzyniak, B
    Wenk, G
    Wyss-Coray, T
    [J]. NEUROBIOLOGY OF AGING, 2000, 21 (03) : 383 - 421
  • [2] The chemistry of melatonin's interaction with reactive species
    Allegra, M
    Reiter, RJ
    Tan, DX
    Gentile, C
    Tesoriere, L
    Livrea, MA
    [J]. JOURNAL OF PINEAL RESEARCH, 2003, 34 (01) : 1 - 10
  • [3] HYDROGEN-PEROXIDE MEDIATES AMYLOID-BETA PROTEIN TOXICITY
    BEHL, C
    DAVIS, JB
    LESLEY, R
    SCHUBERT, D
    [J]. CELL, 1994, 77 (06) : 817 - 827
  • [4] Effect of melatonin on NF-kappa B DNA-binding activity in the rat spleen
    Chuang, JI
    Mohan, N
    Meltz, ML
    Reiter, RJ
    [J]. CELL BIOLOGY INTERNATIONAL, 1996, 20 (10) : 687 - 692
  • [5] Pharmacological action of melatonin in shock, inflammation and ischemia/reperfusion injury
    Cuzzocrea, S
    Reiter, RJ
    [J]. EUROPEAN JOURNAL OF PHARMACOLOGY, 2001, 426 (1-2) : 1 - 10
  • [6] ESTERBAUER H, 1990, METHOD ENZYMOL, V186, P407
  • [7] Melatonin inhibits expression of the inducible isoform of nitric oxide synthase in murine macrophages:: role of inhibition of NFκB activation
    Gilad, E
    Wong, HR
    Zingarelli, B
    Virág, L
    O'Connor, M
    Salzman, AL
    Szabó, C
    [J]. FASEB JOURNAL, 1998, 12 (09) : 685 - 693
  • [8] Guerrero Juan M., 2002, Current Topics in Medicinal Chemistry, V2, P167, DOI 10.2174/1568026023394335
  • [9] Subacute NO generation induced by Alzheimer's β-amyloid in the living brain:: reversal by inhibition of the inducible NO synthase
    Ishii, K
    Muelhauser, F
    Liebl, U
    Picard, M
    Kühl, S
    Penke, B
    Bayer, T
    Wiessler, M
    Hennerici, M
    Beyreuther, K
    Hartmann, T
    Fassbender, K
    [J]. FASEB JOURNAL, 2000, 14 (11) : 1485 - 1489
  • [10] Lezoualc'h F, 1998, J NEUROSCI, V18, P3224